News

Presidential Proclamation

Presidential Proclamation

September 1, 2015

"Ovarian cancer is difficult to detect early -- there is no simple and reliable way to screen for it and symptoms are often not clear until later stages. By recognizing possible warning signs and unexplained changes, women can increase their likelihood of detecting ovarian cancer in its early stages when treatment is most effective and the chances for recovery are greatest. To bolster these efforts, my Administration has continued to invest in innovative research to improve early detection and treatment of ovarian cancer, and we are working hard to increase public awareness among women about all types of gynecological cancers." -President Barack Obama To read more, click the plus sign.

NASCAR’s Martin Truex’s girlfriend Sherry Polle...

NASCAR’s Martin Truex’s girlfriend Sherry Pollex goes to Capitol Hill to advocate for affordable therapy costs, ovarian cancer research funding

July 15, 2015

NASCAR’s Martin Truex Jr.’s girlfriend Sherry Pollex goes to Capitol Hill to advocate for affordable therapy costs, ovarian cancer research funding Pollex, Ovarian Cancer National Alliance support Cancer Treatment Parity … Continued

ASCO 2015 Update

ASCO 2015 Update

June 22, 2015

Several promising advances in the treatment of ovarian cancer were presented at this year’s annual meeting of the American Society of Clinical Oncologists (ASCO). Below is a report from one of our Research Advocates, Katie Hoody. Click the plus sign to read Katie's report.

AACR Update

AACR Update

May 18, 2015

Research Advocate Seana Roubinek attended the 2015 American Association of Cancer Research Annual Meeting in April.  Here is her report:  “As a two-time cancer ovarian cancer survivor, I have had … Continued

New Affordable Care Act guidance says women with ovarian ca...

New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing

May 12, 2015

FOR IMMEDIATE RELEASE May 12, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org (202) 517-6410 New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing WASHINGTON, DC—Yesterday, … Continued

ACA Update

ACA Update

May 12, 2015

New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing. On May 11, 2015, the U.S. Department of Health and Human Services, Labor and Treasury issued new guidance to clarify services and coverage available under the Affordable Care Act. Before today, only women with a family history of ovarian and breast cancer were eligible for genetic testing and counseling free from additional out-of-pocket expense. Click the plus sign to read on...

Pelvic Exam Guidelines

Pelvic Exam Guidelines

July 1, 2014

The American College of Physicians recently recommended that women do not need to have a pelvic exam on an annual basis. Current evidence suggests that the pelvic exam is not helpful as a routine screening test for women with an average risk of developing ovarian cancer.

Report from the 2014 American Society of Clinical Oncology ...

Report from the 2014 American Society of Clinical Oncology Annual Meeting

June 17, 2014

Promising new combination treatments for ovarian cancer Dr. Joyce Liu, MD, on behalf of researchers from the National Cancer Institute (NCI) and Dana Farber Cancer Institute (DFCI), presented striking results … Continued

2014 ASCO Research Round-Up

2014 ASCO Research Round-Up

June 6, 2014

Posted by Laura Koontz on June 5, 2014 The 50th Annual Conference of the American Society of Clinical Oncology, held May 30 – June 3 in Chicago, featured a number of promising and thought … Continued

Few women offered genetic counseling services for breast an...

Few women offered genetic counseling services for breast and ovarian cancer risk

May 14, 2014

Despite recommendations from the federal government that women at high-risk of developing breast and ovarian cancer be offered genetic counseling and testing at no out of pocket cost, a new … Continued

Alliance submits comments to FDA on off-label use of oncolo...

Alliance submits comments to FDA on off-label use of oncology drugs

May 2, 2014

This week, the Ovarian Cancer National Alliance submitted comments to the Food and Drug Administration (FDA) about a proposed Guidance for Industry that could have the effect of limiting patient … Continued

SGO and AACR Research Round-Up

SGO and AACR Research Round-Up

April 18, 2014

With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in … Continued